Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Travel Med Infect Dis ; 41: 102028, 2021.
Article in English | MEDLINE | ID: mdl-33737162

ABSTRACT

BACKGROUND: Antimicrobial resistance is increased by international mobility. We present data about intestinal colonization of travelers departing from a middle-income country. METHODS: Travelers were recruited from 2015 to 2019, collected an anal stool specimen and answered a questionnaire before and after travel. Enterobacterales isolates were investigated for antimicrobial resistance; extended-spectrum beta-lactamase (ESBL) and carbapenemase production; plasmid-encoded cephalosporinases (pAmpC), plasmid-mediated quinolone resistance (PMQR) and mcr genes by PCR and sequencing; and association with travel related variables. RESULTS: Among 210 travelers, 26 (12%) carried multidrug-resistant Enterobacterales (MDR-E) and 18 (9%) ESBL-producing Enterobacterales (ESBL-E) before travel, with an increased prevalence from 1% to 11% over the study years. Acquisition of MDR-E and ESBL-E occurred in 59 (32%) and 43 (22%) travelers, respectively, mostly blaCTX-M-15 carrying Escherichia coli. One traveler acquired one isolate carrying blaOXA-181 gene, and two others, isolates carrying mcr-1. PMQR were detected in 14 isolates of returning travelers. The risk of MDR-E acquisition was higher in Southeast Asia and the Indian subcontinent, and after using antimicrobial agents. CONCLUSION: We describe an increasing pre-travel prevalence of ESBL-E colonization in subjects departing from this middle-income country over time. Travel to known risk areas and use of antimicrobial agents during travel were associated with acquisition of MDR-E. Travel advice is critical to mitigating this risk, as colonization by MDR-E may raise the chances of antimicrobial-resistant infections.


Subject(s)
Anti-Bacterial Agents , Travel , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Drug Resistance, Bacterial/genetics , Humans , Travel-Related Illness , beta-Lactamases/genetics
2.
Rev Soc Bras Med Trop ; 52: e20190014, 2019 Jun 06.
Article in English | MEDLINE | ID: mdl-31188918

ABSTRACT

INTRODUCTION: Malaria is the main cause of death by infection among travelers and is preventable through a combination of chemoprophylaxis and personal protective measures. METHODS: Travelers were interviewed by phone 28-90 days after returning, to assess adherence to pre-travel advice for malaria prevention. RESULTS: A total 57 travelers were included. Adherence to chemoprophylaxis was significantly higher among participants prescribed mefloquine (n=18; 75%) than doxycycline (n=14; 45%). Adherence to mosquito repellent and bed net use was 65% and 67%, respectively. CONCLUSIONS: Adherence to malaria prophylaxis was lower than expected. Further studies testing innovative approaches to motivate travelers' compliance are required.


Subject(s)
Antimalarials/therapeutic use , Doxycycline/therapeutic use , Malaria/drug therapy , Malaria/prevention & control , Medication Adherence/statistics & numerical data , Mefloquine/therapeutic use , Pre-Exposure Prophylaxis/statistics & numerical data , Adult , Female , Humans , Male , Middle Aged , Travel
3.
Rev. Soc. Bras. Med. Trop ; 52: e20190014, 2019. tab
Article in English | LILACS | ID: biblio-1041595

ABSTRACT

Abstract INTRODUCTION: Malaria is the main cause of death by infection among travelers and is preventable through a combination of chemoprophylaxis and personal protective measures. METHODS: Travelers were interviewed by phone 28-90 days after returning, to assess adherence to pre-travel advice for malaria prevention. RESULTS: A total 57 travelers were included. Adherence to chemoprophylaxis was significantly higher among participants prescribed mefloquine (n=18; 75%) than doxycycline (n=14; 45%). Adherence to mosquito repellent and bed net use was 65% and 67%, respectively. CONCLUSIONS: Adherence to malaria prophylaxis was lower than expected. Further studies testing innovative approaches to motivate travelers' compliance are required.


Subject(s)
Humans , Male , Female , Adult , Mefloquine/therapeutic use , Doxycycline/therapeutic use , Medication Adherence/statistics & numerical data , Pre-Exposure Prophylaxis/statistics & numerical data , Malaria/prevention & control , Malaria/drug therapy , Antimalarials/therapeutic use , Travel , Middle Aged
4.
Rev Soc Bras Med Trop ; 51(2): 125-132, 2018.
Article in English | MEDLINE | ID: mdl-29768543

ABSTRACT

Providing advice for travelers embarking on long-term trips poses a challenge in travel medicine. A long duration of risk exposure is associated with underuse of protective measures and poor adherence to chemoprophylaxis, increasing the chances of acquiring infections. Recently, in our clinic, we observed an increase in the number of travelers undertaking round-the-world trips. These individuals are typically aged around 32 years and quit their jobs to embark on one-to-two-year journeys. Their destinations include countries in two or more continents, invariably Southeast Asia and Indonesia, and mostly involve land travel and visiting rural areas. Such trips involve flexible plans, increasing the challenge, especially with regard to malaria prophylaxis. Advising round-the-world travelers is time-consuming because of the amount of information that must be provided to the traveler. Advisors must develop strategies to commit the traveler to his/her own health, and verify their learnings on disease-prevention measures. Contacting the advisor after the appointment or during the trip can be helpful to clarify unclear instructions or diagnosis made and prescriptions given abroad. Infectious diseases are among the most frequent problems affecting travelers, many of which are preventable by vaccines, medicines, and precautionary measures. The dissemination of counterfeit medicines, particularly antibiotics and antimalarial medicines, emphasizes the need for travelers to carry medicines that they may possibly need on their trip. Additional advice on altitude, scuba diving, and other possible risks may also be given. Considering the difficulties in advising this group, we present a review of the main recommendations on advising these travelers.


Subject(s)
Communicable Disease Control/methods , Travel Medicine/trends , Travel , Communicable Disease Control/trends , Counseling , Humans
5.
Rev. Soc. Bras. Med. Trop ; 51(2): 125-132, Mar.-Apr. 2018. tab
Article in English | LILACS | ID: biblio-897061

ABSTRACT

Abstract Providing advice for travelers embarking on long-term trips poses a challenge in travel medicine. A long duration of risk exposure is associated with underuse of protective measures and poor adherence to chemoprophylaxis, increasing the chances of acquiring infections. Recently, in our clinic, we observed an increase in the number of travelers undertaking round-the-world trips. These individuals are typically aged around 32 years and quit their jobs to embark on one-to-two-year journeys. Their destinations include countries in two or more continents, invariably Southeast Asia and Indonesia, and mostly involve land travel and visiting rural areas. Such trips involve flexible plans, increasing the challenge, especially with regard to malaria prophylaxis. Advising round-the-world travelers is time-consuming because of the amount of information that must be provided to the traveler. Advisors must develop strategies to commit the traveler to his/her own health, and verify their learnings on disease-prevention measures. Contacting the advisor after the appointment or during the trip can be helpful to clarify unclear instructions or diagnosis made and prescriptions given abroad. Infectious diseases are among the most frequent problems affecting travelers, many of which are preventable by vaccines, medicines, and precautionary measures. The dissemination of counterfeit medicines, particularly antibiotics and antimalarial medicines, emphasizes the need for travelers to carry medicines that they may possibly need on their trip. Additional advice on altitude, scuba diving, and other possible risks may also be given. Considering the difficulties in advising this group, we present a review of the main recommendations on advising these travelers.


Subject(s)
Humans , Travel , Communicable Disease Control/methods , Travel Medicine/trends , Communicable Disease Control/trends , Counseling
6.
Rev Soc Bras Med Trop ; 49(4): 527-9, 2016.
Article in English | MEDLINE | ID: mdl-27598646

ABSTRACT

Sporotrichosis is the most common subcutaneous mycosis in South America and its association with zoonotic transmission remains a relevant public health problem in Rio de Janeiro, Brazil. The disease most commonly presents as subacute or chronic cutaneous lesions, although dissemination to various organs and systems occurs in rare cases, mainly in immunosuppressed individuals. This report describes a case of sporotrichosis with severe bone and subcutaneous damage in an immunocompetent patient who did not exhibit the characteristic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis.


Subject(s)
Osteomyelitis/microbiology , Sporotrichosis/complications , Adult , Humans , Immunocompetence , Magnetic Resonance Imaging , Male , Osteomyelitis/diagnosis , Sporotrichosis/diagnosis
7.
Rev. Soc. Bras. Med. Trop ; 49(4): 527-529, July-Aug. 2016. graf
Article in English | LILACS | ID: lil-792798

ABSTRACT

Abstract Sporotrichosis is the most common subcutaneous mycosis in South America and its association with zoonotic transmission remains a relevant public health problem in Rio de Janeiro, Brazil. The disease most commonly presents as subacute or chronic cutaneous lesions, although dissemination to various organs and systems occurs in rare cases, mainly in immunosuppressed individuals. This report describes a case of sporotrichosis with severe bone and subcutaneous damage in an immunocompetent patient who did not exhibit the characteristic skin lesions of sporotrichosis, including ulcers, nodules, and lymphangitis.


Subject(s)
Humans , Male , Adult , Osteomyelitis/microbiology , Sporotrichosis/complications , Osteomyelitis/diagnosis , Sporotrichosis/diagnosis , Magnetic Resonance Imaging , Immunocompetence
8.
Rio de Janeiro; s.n; 2011. xiii,76 p. ilus, tab, graf.
Thesis in Portuguese | LILACS | ID: lil-588854

ABSTRACT

A Leishmaniose Tegumentar Americana (LTA) é uma doença que se caracteriza pela presença de lesões cultâneas (LCL) e, em um número pequeno de pacientes, pelo desenvolvimento de lesão mucosa (ML). A evolução clínica e a resposta ao tratamento dependem de múltiplos fatores, incluindo o equilíbrio entre as citocinas Th1 e Th2, influenciando no controle parasitário e na extensão da lesão. Nesse equilíbrio complexo é possível que outras citocinas inflamatórias como IL-17 e IL-18, bem como fatores que influenciem na diferenciação de queratinócitos e nos processos inflamatórios da pele, como o sistema Notch, também possam se relacionar ao prognóstico das lesões. IL-18 é uma potente citocina indutora de IFN-gama, já tendo sido observado efeito protetor em doenças por protozoários. IL-17 é produzida por uma linhagem de células T descritas mais recentemente, que são consideradas essenciais em processos inflamatórios de vários tecidos e em doenças auto-imunes. O sistema de sinalização Notch é composto por um grupo de proteínas transmembrana que regulam processos decisórios em diversos tecidos, tanto no período embrionário como na vida adulta, incluindo a diferenciação de queratinócitos e de linfócitos T, na dependência do ligante envolvido em sua ativação (Delta-like – DLL1/DLL3/DLL4 ou Jagged 1 e 2). Estudamos a expressão das proteínas do sistema Notch e das citocinas IL-17 e IL-18 em lesões e sangue de pacientes com LTA causada por Leishmania (Viannia) braziliensis, comparando os níveis de expressão de acordo com o tempo de evolução das lesões, diâmetro da reação de Montenegro e resposta ao tratamento. As lesões cutâneas de LTA apresentam maior expressão de receptores Notch que a pele normal...


Subject(s)
Cytokines , Gene Expression , Immunity, Cellular , Interleukins , Leishmaniasis, Cutaneous/therapy , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...